News of Note—Recro and Novartis extend pact

Woman typing on computer
Pacira Pharmaceuticals says that CMDO Thermo Fisher Scientific Pharma Services has started commercial production of its a surgical pain drug Exparel. (Max Pixel CC0)

> Recro Pharma has entered into a five-year manufacturing and supply agreement with Novartis to continue to be the exclusive global supplier of Ritalin LA and Focalin XR capsules through 2023. Release

> Pacira Pharmaceuticals says that CMDO Thermo Fisher Scientific Pharma Services has started commercial production of its a surgical pain drug Exparel at a facility in the U.K. that is expected to double the company’s manufacturing capacity. Release

> Women’s health focused Mithra says it has successfully produced its first commercial batch of vaginal contraceptive Myring for the European market. Release (PDF)

 

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)